SARS-CoV-2 Rapid Antigen Test
Reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Nice results
Is a good product that offers good value for money, easy to use for rapid results on early detection
Is efficient and is great quality. Normal person can use.
Review Date: 4 Feb 2023 | Roche
Excellent
Test for Covid
Very good
Review Date: 29 Mar 2022 | Roche
Great results.
Analysis of antibodies
Is efficient and is great quality.
Review Date: 23 Jul 2021 | Roche
Great value for money.
Clinical diagnosis
Is a good product that offers good value for money, easy to use for rapid results on early detection of Covid 19.
Review Date: 6 Jun 2021 | Roche
The SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatopgraphic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx.
This test is an aid in detecting antigen from the SARS-CoV-2 virus in individuals suspected of COVID-19. This product is strictly intended for professional use in laboratory and Point of Care environment.
Roche announced the launch of three molecular PCR diagnostic test panels to detect and differentiate common respiratory pathogens simultaneously
The three new respiratory test panels on cobas 6800/8800 Systems in CE markets will help identify multiple pathogens with overlapping symptoms in patients
Roche’s Actemra/RoActemra receives FDA EUA for the treatment of COVID-19
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
